EVZIO Drug Patent Profile
✉ Email this page to a colleague
When do Evzio patents expire, and what generic alternatives are available?
Evzio is a drug marketed by Kaleo Inc and is included in two NDAs. There are thirty-four patents protecting this drug.
This drug has one hundred and forty-three patent family members in fifteen countries.
The generic ingredient in EVZIO is naloxone hydrochloride. There are twelve drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the naloxone hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Evzio
A generic version of EVZIO was approved as naloxone hydrochloride by HOSPIRA on September 24th, 1986.
Summary for EVZIO
| International Patents: | 143 |
| US Patents: | 33 |
| Applicants: | 1 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 56 |
| Patent Applications: | 1,704 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for EVZIO |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for EVZIO |
| What excipients (inactive ingredients) are in EVZIO? | EVZIO excipients list |
| DailyMed Link: | EVZIO at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for EVZIO
US Patents and Regulatory Information for EVZIO
EVZIO is protected by thirty-three US patents.
Patents protecting EVZIO
Ultrafiltration membrane and a preparation method thereof
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: USE OF A DELIVERY DEVICE TO DELIVER A DOSE OF NALOXONE
Devices and methods for delivering opioid antagonists including formulations for naloxone
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: USE OF A DELIVERY DEVICE TO DELIVER A BIOEQUIVALENT DOSE OF A NALOXONE COMPOSITION VIA A NEEDLE
Devices, systems and methods for medicament delivery
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Medicament delivery device for administration of opioid antagonists including formulations for naloxone
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: USE OF A DELIVERY DEVICE TO ADMINISTER A DOSE OF NALOXONE
Devices, systems and methods for medicament delivery
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Devices, systems and methods for medicament delivery
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Devices, systems and methods for medicament delivery
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Devices, systems and methods for medicament delivery
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Devices, systems and methods for medicament delivery
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Devices, systems, and methods for medicament delivery
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Devices, systems and methods for medicament delivery
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Devices, systems and methods for medicament delivery
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Devices, systems and methods for medicament delivery
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Medicament delivery device configured to produce an audible output
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Devices, systems and methods for medicament delivery
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Medical injector with compliance tracking and monitoring
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Medicament delivery device having an electronic circuit system
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Devices, systems and methods for medicament delivery
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Devices, systems and methods for medicament delivery
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Devices, systems, and methods for medicament delivery
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Devices, systems and methods for medicament delivery
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Medicament delivery device for administration of opioid antagonists including formulations for naloxone
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Devices, systems and methods for medicament delivery
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Medicament delivery device for administration of opioid antagonists including formulations for naloxone
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Medicament delivery device for administration of opioid antagonists including formulations for naloxone
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Devices, systems and methods for medicament delivery
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Medicament delivery device having an electronic circuit system
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Devices, systems and methods for medicament delivery
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Medicament delivery device for administration of opioid antagonists including formulations for naloxone
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: USE OF A DELIVERY DEVICE TO ADMINISTER A DOSE OF NALOXONE
Devices and methods for delivering opioid antagonists including formulations for naloxone
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: USE OF AN AUTO INJECTOR TO ADMINISTER NALOXONE HCL
Devices, systems, and methods for medicament delivery
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: METHOD FOR CONFIRMING DOSE DELIVERY
Devices, systems and methods for medicament delivery
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Kaleo Inc | EVZIO (AUTOINJECTOR) | naloxone hydrochloride | SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS | 209862-001 | Oct 19, 2016 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| Kaleo Inc | EVZIO | naloxone hydrochloride | SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS | 205787-001 | Apr 3, 2014 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| Kaleo Inc | EVZIO (AUTOINJECTOR) | naloxone hydrochloride | SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS | 209862-001 | Oct 19, 2016 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| Kaleo Inc | EVZIO (AUTOINJECTOR) | naloxone hydrochloride | SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS | 209862-001 | Oct 19, 2016 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| Kaleo Inc | EVZIO (AUTOINJECTOR) | naloxone hydrochloride | SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS | 209862-001 | Oct 19, 2016 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| Kaleo Inc | EVZIO (AUTOINJECTOR) | naloxone hydrochloride | SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS | 209862-001 | Oct 19, 2016 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for EVZIO
See the table below for patents covering EVZIO around the world.
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| Canada | 2825600 | DISPOSITIFS D'ADMINISTRATION DE MEDICAMENT POUR L'ADMINISTRATION D'UN MEDICAMENT A L'INTERIEUR D'UNE SERINGUE PRE-REMPLIE (MEDICAMENT DELIVERY DEVICES FOR ADMINISTRATION OF A MEDICAMENT WITHIN A PREFILLED SYRINGE) | ⤷ Try a Trial |
| Australia | 2009200841 | Devices, systems, and methods for medicament delivery | ⤷ Try a Trial |
| Japan | 2012508081 | ⤷ Try a Trial | |
| Denmark | 2285360 | ⤷ Try a Trial | |
| United Kingdom | 201315737 | ⤷ Try a Trial | |
| Japan | 5599500 | ⤷ Try a Trial | |
| >Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for EVZIO
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1685839 | 92292 | Luxembourg | ⤷ Try a Trial | PRODUCT NAME: COMBINAISON D OXYCODONE EN TANT QUE COMPOSANT A ET DE NALOXONE EN TANT QUE COMPOSANT B SOUS TOUTES LES FORMES PROTEGES PAR LE BREVET DE BASE |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Make Better Decisions: Try a trial or see plans & pricing
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
